7459 — Medipal Holdings Share News
0.000.00%
- ¥530bn
- ¥385bn
- ¥4tn
Table: Medipal Holdings -Q1 group results
Brief: R&I upgrades Medipal Holdings' rating to "A+" and says stable outlook -R&I
Brief: Medipal Holdings lowers conversion price of 2022 due euro-yen denominated convertible bonds with warrants
Table: Medipal Holdings -2017/18 group results
Table: Medipal Holdings -2017/18 parent results
Table: Medipal Holdings -2017/18 div forecast
Table: Medipal Holdings - 9-MTH group results
Brief: Medipal Holdings signs contract to set up JV JCR USA with JCR Pharmaceuticals
Table: Medipal Holdings - 6-MTH group results
Table: Medipal Holdings -2017/18 group forecast
Table: Medipal Holdings Corp -2017 6-month group forecast
Brief: Medipal Holdings says conversion price of 2022 due euro-yen denominated convertible bonds with warrants
Brief: Medipal Holdings completes share repurchase through ToSTNeT-3
Brief: Medipal Holdings to issue 2022 due euro-yen denominated convertible bonds with subscription warrants
Brief: JCR Pharmaceuticals announces shareholding structure change
Brief: JCR Pharmaceuticals announces business and capital alliance with Medipal Holdings
Brief: Medipal Holdings to repurchase shares through ToSTNeT-3
Table: Medipal Holdings -Q1 group results
Table: Medipal Holdings -2016/17 div forecast